May 13, 2025NeuroOne Medical Technologies Corporation misses on earnings expectations. Reported EPS is $-72.98221 EPS, expectations were $-0.09. Operator: Good day, ladies and gentlemen. Welcome to ...

Between 2022 and 2027, leading data and analytics company GlobalData forecasts show cybersecurity spending by healthcare ...

It is not a requirement for marketing such devices that the name of the device has been proved to correspond to what is ...

Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...

A Boston Duck Tours guide is back to work after a groundbreaking aortic aneurysm repair at Tufts Medical Center, thanks to a ...

The Teal Wand is an at-home vaginal self-collection device intended to test for 14 types of high-risk HPV that have the ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

The FDA has approved the first at-home cervical cancer screening device, designed to make women feel more comfortable with ...

A Cornell University project to save babies born with serious heart defects has lost key funding just days after it was ...

The FDA approved the first at-home screening test for cervical cancer on May 9, a move experts anticipate will help boost screening rates across the country. Five notes: 1. The test kit is made by ...

Meanwhile, Axios reports the FDA is making plans to use AI in its decision-making. Also: President Donald Trump is set to sign an executive order to bring down the cost of meds.